A Study Evaluating Sleep, Stress and Infant Nutrition Using a Chatbot

August 2, 2020 updated by: Danone Asia Pacific Holdings Pte, Ltd.

A Pilot Study Evaluating Sleep, Stress, and Infant Nutrition Using a Chatbot With Parents of Preterm and Full-term Infants

20 parents with healthy preterm infants (born at <37 weeks of gestation), age 0-6 months and discharged from the hospital at time of enrollment and 20 parents with healthy full-term infants (born at ≥37 weeks of gestation), age 0-6 months and discharged from the hospital at time of enrollment will be enrolled to obtain records of sleep, stress, and infant nutrition from parents of infants (preterm and full-term) through interaction with the study chatbot.

Study Overview

Status

Completed

Conditions

Detailed Description

20 parents with healthy preterm infants (born at <37 weeks of gestation), age 0-6 months and discharged from the hospital at time of enrollment and 20 parents with healthy full-term infants (born at ≥37 weeks of gestation), age 0-6 months and discharged from the hospital at time of enrollment will be enrolled to obtain records of sleep, stress, and infant nutrition from parents of infants (preterm and full-term) through interaction with the study chatbot.

Data obtained from parents of preterm infants and parents of full-term infants on sleep, stress, and infant nutrition will be compared.

An evaluation of the usability of the mobile app hosting the chatbot, the study chatbot and its functionality in general among this population will also be conducted

Study Type

Observational

Enrollment (Actual)

45

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Singapore, Singapore
        • KK Women's and Children's Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

No older than 6 months (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

  • 20 parents with healthy preterm infants (born at <37 weeks of gestation), age 0-6 months and discharged from the hospital at time of enrollment
  • 20 parents with healthy full-term infants (born at ≥37 weeks of gestation), age 0-6 months and discharged from the hospital at time of enrollment

Description

Inclusion Criteria:

Subjects (parent and infant) must meet the following criteria:

  • Healthy infants (preterm and full-term) must be 0-6 months of age at time of enrollment
  • Infants must be at home (discharged from the hospital) at time of enrollment
  • Informed consent from parent whose age is ≥21 years
  • Parent must be proficient in the English language
  • Parent must be able to comply with the required study tasks, as per PI's judgment
  • In-home access to reliable internet connections; a mobile device suitable for electronic communication

Exclusion Criteria:

Infant must not meet any of the following criteria:

  • Known to have current or previous illnesses/conditions which could interfere with the study outcome (per PI's clinical judgment)
  • Must not be currently participating in any other clinical study

Parent must not meet any of the following criteria:

  • Must not be known to have a significant medical condition that might interfere with the study (per PI's clinical judgment) that meets one of the following criteria:
  • Presence of current mental illness or history of mental illness
  • Any acute or chronic illness that makes the parent unsuitable for the study based on the PI's judgment
  • Must not be a single parent
  • Inability of the parent to comply with the study protocol or PI's uncertainty about the willingness or ability of the parent to comply with the protocol requirements

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Preterm
born at <37 weeks of gestation
Full term Term
born at >/= 37 weeks of gestation

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of Chats on Sleep, Stress and Infant Nutrition
Time Frame: 8 weeks
Obtaining number of chats for sleep, stress, and infant nutrition from parents of infants (preterm and full-term) through interaction with the study chatbot
8 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Ratings by Parents of Quality of Their Sleep
Time Frame: 8 weeks
Comparison on ratings for quality of their (parent) sleep from parents of preterm infants and parents of full-term infants
8 weeks
Particular Reasons for Stress Caused by the Baby
Time Frame: 8 weeks
Comparison of particular reasons for stress caused by the baby from parents of preterm infants and parents of full-term infants
8 weeks
Number of Chats on Feedings Among Parents Who Give Their Infants Formula
Time Frame: 8 weeks
Comparison of number of chats on the feeding from parents of preterm infants and parents of full-term infants who give their infants formula
8 weeks

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Satisfaction Scale Scores for Chatbot and ClaimIt
Time Frame: 8 weeks
Satisfaction scale scores for Chatbot and ClaimIt based on a scale score of 1 (very dissatisfied) to 5 (very satisfied) on the Usability of Chatbot and ClaimIt eQuestionnaire
8 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Mei Chien Chua, MBBS, KK Women's and Children's Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 7, 2018

Primary Completion (Actual)

March 1, 2019

Study Completion (Actual)

May 9, 2019

Study Registration Dates

First Submitted

July 17, 2018

First Submitted That Met QC Criteria

August 10, 2018

First Posted (Actual)

August 15, 2018

Study Record Updates

Last Update Posted (Actual)

August 13, 2020

Last Update Submitted That Met QC Criteria

August 2, 2020

Last Verified

August 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • OBVIO-DAN-003

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy

3
Subscribe